Terms: = Head and neck cancer AND FHIT, P49789, FRA3B, AP3Aase, ENSG00000189283, 2272 AND Clinical Outcome
6 results:
1. Combined TP53 mutation/3p loss correlates with decreased radiosensitivity and increased matrix-metalloproteinase activity in head and neck carcinoma.
Raju SC; Hauff SJ; Lemieux AJ; Orosco RK; Gross AM; Nguyen LT; Savariar E; Moss W; Whitney M; Cohen EE; Lippman SM; Tsien RY; Ideker T; Advani SJ; Nguyen QT
Oral Oncol; 2015 May; 51(5):470-5. PubMed ID: 25735654
[TBL] [Abstract] [Full Text] [Related]
2. The degree of segmental aneuploidy measured by total copy number abnormalities predicts survival and recurrence in superficial gastroesophageal adenocarcinoma.
Davison JM; Yee M; Krill-Burger JM; Lyons-Weiler MA; Kelly LA; Sciulli CM; Nason KS; Luketich JD; Michalopoulos GK; LaFramboise WA
PLoS One; 2014; 9(1):e79079. PubMed ID: 24454681
[TBL] [Abstract] [Full Text] [Related]
3. Clinicopathological significance of the fragile histidine triad transcription protein expression in laryngeal carcinogenesis.
Kitamura K; Hayashi K; Kobayashi R; Ishii H; Matsubayashi J; Matsumoto T; Suzuki M
Oncol Rep; 2008 Apr; 19(4):847-52. PubMed ID: 18357366
[TBL] [Abstract] [Full Text] [Related]
4. Molecular predictors of clinical outcome in patients with head and neck squamous cell carcinoma.
Thomas GR; Nadiminti H; Regalado J
Int J Exp Pathol; 2005 Dec; 86(6):347-63. PubMed ID: 16309541
[TBL] [Abstract] [Full Text] [Related]
5. Altered p16INK4a and fhit expression in carcinogenesis and progression of human oral cancer.
Paradiso A; Ranieri G; Stea B; Zito A; Zehbe I; Tommasino M; Grammatica L; De Lena M
Int J Oncol; 2004 Feb; 24(2):249-55. PubMed ID: 14719099
[TBL] [Abstract] [Full Text] [Related]
6. Loss of fhit expression is a predictor of poor outcome in tongue cancer.
Lee JI; Soria JC; Hassan K; Liu D; Tang X; El-Naggar A; Hong WK; Mao L
Cancer Res; 2001 Feb; 61(3):837-41. PubMed ID: 11221865
[TBL] [Abstract] [Full Text] [Related]
